American Capital Advisory’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
American Capital Advisory's DXCM Position: Q3 2026 in Review
American Capital Advisory increased its DexCom (DXCM) stake by 0.37% in Q3 2026, buying an estimated $83 and bringing the position to 270 shares worth $23.3K. The position accounts for 0.01% of the portfolio, ranked #295.
American Capital Advisory first reported a position in DXCM in Q4 2023 and has held it in 10 quarters since. The position peaked at $23.6K in Q2 2024. 1,056 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.
- American Capital Advisory held 270 shares of DexCom worth $23.3K as of Q3 2026.
- American Capital Advisory bought 1 DexCom share in Q3 2026, an estimated $83.
- DexCom made up 0.01% of American Capital Advisory's portfolio in Q3 2026, its #295 holding.
- American Capital Advisory first reported a position in DexCom in Q4 2023 and has held it in 10 quarters since.
- American Capital Advisory's DexCom position peaked at $23.6K in Q2 2024.
- 1,056 funds tracked by Wall St. Rank held DexCom as of Q3 2026.
Based on American Capital Advisory's 13F filing for Q3 2026, filed 28 Oct 2026.